Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited has informed the NSE that its trading window will be closed from October 1, 2025, until 48 hours after the declaration of its unaudited financial results for the half year ended September 30, 2025 (H1 FY26). During this period, directors, officers, designated employees, their immediate relatives, and other covered persons are prohibited from trading in the company's shares. The closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's own insider trading code. This is a routine compliance filing made ahead of the upcoming half-yearly results announcement.
This is a standard regulatory disclosure and not material on its own. However, it signals that the company's H1 FY26 financial results will be announced soon, which investors should watch for as it could influence the stock price.